BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 23828549)

  • 1. Mucin phenotype expression of gastric neuroendocrine neoplasms: analysis of histopathology and carcinogenesis.
    Domori K; Nishikura K; Ajioka Y; Aoyagi Y
    Gastric Cancer; 2014 Apr; 17(2):263-72. PubMed ID: 23828549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-evaluation of phenotypic expression in undifferentiated-type early gastric adenocarcinomas using mucin core protein and CDX2.
    Ikarashi S; Nishikura K; Ajioka Y; Aoyagi Y
    Gastric Cancer; 2013 Apr; 16(2):208-19. PubMed ID: 22829163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinicopathologic and immunohistochemical study on early gastric signet-ring cell carcinoma].
    Xiong ZF; Xiao H; Tan YS
    Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):442-6. PubMed ID: 21055171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: II. Expression of MUC1, MUC2, MUC5AC, and MUC6 in normal mucosa and in 42 cases.
    Terada T
    Int J Clin Exp Pathol; 2013; 6(4):613-21. PubMed ID: 23573307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatoid adenocarcinoma of the stomach: histogenesis and progression in association with intestinal phenotype.
    Kumashiro Y; Yao T; Aishima S; Hirahashi M; Nishiyama K; Yamada T; Takayanagi R; Tsuneyoshi M
    Hum Pathol; 2007 Jun; 38(6):857-63. PubMed ID: 17320150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship among PDX1, CDX2, and mucin profiles in gastric carcinomas; correlations with clinicopathologic parameters.
    Oz Puyan F; Can N; Ozyilmaz F; Usta U; Sut N; Tastekin E; Altaner S
    J Cancer Res Clin Oncol; 2011 Dec; 137(12):1749-62. PubMed ID: 21909647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-evaluation of mucin phenotypes of gastric minute well-differentiated-type adenocarcinomas using a series of HGM, MUC5AC, MUC6, M-GGMC, MUC2 and CD10 stains.
    Shiroshita H; Watanabe H; Ajioka Y; Watanabe G; Nishikura K; Kitano S
    Pathol Int; 2004 May; 54(5):311-21. PubMed ID: 15086835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDX2 expression is increased in gastric cancers with less invasiveness and intestinal mucin phenotype.
    Ha Kim G; Am Song G; Youn Park D; Han Lee S; Hyun Lee D; Oh Kim T; Jae Jo H; Heo J; Hwan Kang D; Cho M
    Scand J Gastroenterol; 2006 Aug; 41(8):880-6. PubMed ID: 16803685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma.
    Silva EM; Begnami MD; Fregnani JH; Pelosof AG; Zitron C; Montagnini AL; Soares FA
    Gastric Cancer; 2008; 11(3):149-59. PubMed ID: 18825309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
    Tang LH; Basturk O; Sue JJ; Klimstra DS
    Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroenteropancreatic High-Grade Neuroendocrine Neoplasms: Histology and Molecular Analysis, Two Sides of the Same Coin.
    Busico A; Maisonneuve P; Prinzi N; Pusceddu S; Centonze G; Garzone G; Pellegrinelli A; Giacomelli L; Mangogna A; Paolino C; Belfiore A; Kankava K; Perrone F; Tamborini E; Pruneri G; Fazio N; Milione M
    Neuroendocrinology; 2020; 110(7-8):616-629. PubMed ID: 31557757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer.
    Liu Q; Teh M; Ito K; Shah N; Ito Y; Yeoh KG
    Mod Pathol; 2007 Dec; 20(12):1286-97. PubMed ID: 17906616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of MUC2 expression correlates with progression along the adenoma-carcinoma sequence pathway as well as de novo carcinogenesis in the colon.
    Mizoshita T; Tsukamoto T; Inada KI; Hirano N; Tajika M; Nakamura T; Ban H; Tatematsu M
    Histol Histopathol; 2007 Mar; 22(3):251-60. PubMed ID: 17163399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases.
    Murakami T; Yao T; Mitomi H; Morimoto T; Ueyama H; Matsumoto K; Saito T; Osada T; Nagahara A; Watanabe S
    Gastric Cancer; 2016 Apr; 19(2):498-507. PubMed ID: 25893262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
    Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
    Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precursor-derived versus de-novo carcinogenesis depends on lineage-specific mucin phenotypes of intramucosal gland-forming gastric neoplasms.
    Nishimura R; Mukaisho K; Yamamoto H; Sonoda A; Andoh A; Fujiyama Y; Hattori T; Sugihara H
    Histopathology; 2013 Nov; 63(5):616-29. PubMed ID: 24033890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma.
    Pinto-de-Sousa J; David L; Reis CA; Gomes R; Silva L; Pimenta A
    Virchows Arch; 2002 Mar; 440(3):304-10. PubMed ID: 11889602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori-negative Differentiated Adenocarcinoma of the Stomach.
    Nagaya T; Tanaka N; Iwaya Y; Jimbo Y; Tatai T; Ito T; Seki A; Suzawa K; Ochi Y; Hara E; Takata M; Otsuki T; Iwaya M; Hosaka N; Arakura N; Tanaka E; Hasebe O
    Intern Med; 2015; 54(22):2857-62. PubMed ID: 26567998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes.
    Tsukamoto T; Mizoshita T; Mihara M; Tanaka H; Takenaka Y; Yamamura Y; Nakamura S; Ushijima T; Tatematsu M
    Histopathology; 2005 Jun; 46(6):649-58. PubMed ID: 15910596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of the effect of Helicobacter pylori on the expressions of SOX2, CDX2, MUC2, MUC5AC, MUC6, TFF1, TFF2, and TFF3 mRNAs in human gastric carcinoma cells.
    Matsuda K; Yamauchi K; Matsumoto T; Sano K; Yamaoka Y; Ota H
    Scand J Gastroenterol; 2008 Jan; 43(1):25-33. PubMed ID: 18938748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.